Victor Echevarria
Managing Director @ Jackson Square Ventures
San Francisco, United States
Victor Echevarria is a Series A investor at Jackson Square Ventures in San Francisco focused on Health Care and FinTech. Victor is a Partner at Jackson Square Ventures and joined the team in January of 2018.Victor focuses his investments on early stage marketplace, enterprise, healthcare, and fintech businesses. He recently invested in WELL Health, which provides major health systems with simplified communications between patients and their healthcare providers,where he is a Board Director. Prior to joining JSV in January of 2018, Victor founded Remedy Labs, a healthcare fintech company focused on patient and payer billing accuracy. Victor was a very early team member at TaskRabbit, where he ran marketing and business development, conceptualizing and launching the company's B2B offering. He also spent time as an associate at Benchmark Capital in addition to engineering and product marketing roles at Rambus. A graduate of UC Berkeley and Harvard Business School, Victor lives in San Francisco with his wife and two children.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries Victor Echevarria invests in
Stages Victor Echevarria invests in
Countries Victor Echevarria invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (33%)
- FinTech 2 (17%)
- Hospital 2 (17%)
- Software 2 (17%)
- B2B 1 (8%)
Stage
- Series A 5 (42%)
- Series B 2 (17%)
- Series C 2 (17%)
- Pre-Seed 1 (8%)
- Series D 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Provenance is the system of record for financial models, bringing version control, auditability, and AI-powered change analysis to Excel workflows. It replaces fragmented review processes with a unified platform for tracking, validating, and approving model changes. | $600K / Pre-Seed / Aug 16, 2026 | ||
| Provenance is the system of record for financial models, bringing version control, auditability, and AI-powered change analysis to Excel workflows. It replaces fragmented review processes with a unified platform for tracking, validating, and approving model changes. | Venture - Series Unknown / Feb 26, 2026 | ||
| Clarity Pediatrics is reimagining pediatric chronic care, starting with ADHD. Nearly 10% of American children are diagnosed with ADHD, and for parents it can feel impossible to get the right care. We are building a virtual pediatric ADHD clinic that delivers trusted care to all families. Our new clinical model is tech-enabled, backed by the bestscience, and has the potential to deliver exceptional health outcomes to transform a child’s trajectory. | $14.5M / Series A / Dec 17, 2025 | ||
| Well Health provides a communication platform that connects patients to healthcare organizations through text, email, phone, and live chat. WELL is a communication tool that allows front offices to have two-way text conversations with patients, using existing office phone numbers. The platform is designed from the ground up to make patientcommunications more intuitive across the enterprise. Well Health's mission is to make going to the doctor as easy as meeting up with a close friend. | $65M / Series D / Dec 03, 2025 | ||
| 1upHealth is a health-tech company that builds products for the future of healthcare where value-based care, along with patient and provider applications are the norm. It aims to bridge the gap between patient-centered data and provider needs by using patient-generated data to enable applications to improve healthcare outcomes and reduce costs.Founded in 2017, 1upHealth is based in Boston, MA. | $40M / Series C / Apr 12, 2023 | ||
| Roo is an online veterinary relief service platform that allows vet professionals to secure freelance work.It enables hospitals to fulfill short-term personnel needs in real time while allowing vet professionals to secure freelance work at the click of a button. Both sides provide information on service types, skills, and preferences, ensuring fulltransparency and the best matching. | $11M / Series A / Sep 02, 2022 | ||
| Crowdbotics makes it faster than ever to build complete, scalable apps for business. With Crowdbotics any product manager can turn ideas into real code using a matched library of components and a network of on-call experts. Crowdbotics references a library of millions of production-grade software packages to identify the most effective componentsand workflows for a given project. Crowdbotics then handles infrastructure, implementation, maintenance, operations, monitoring, and security for the life of the project. | $13.4M / Series A / Apr 27, 2021 | ||
| 1upHealth is a health-tech company that builds products for the future of healthcare where value-based care, along with patient and provider applications are the norm. It aims to bridge the gap between patient-centered data and provider needs by using patient-generated data to enable applications to improve healthcare outcomes and reduce costs.Founded in 2017, 1upHealth is based in Boston, MA. | $25M / Series B / Apr 15, 2021 | ||
| Well Health provides a communication platform that connects patients to healthcare organizations through text, email, phone, and live chat. WELL is a communication tool that allows front offices to have two-way text conversations with patients, using existing office phone numbers. The platform is designed from the ground up to make patientcommunications more intuitive across the enterprise. Well Health's mission is to make going to the doctor as easy as meeting up with a close friend. | $45M / Series C / Nov 24, 2020 | ||
| Trust & Will is an online service providing legal forms and information that makes creating estate planning easy, fast, and secure. It is not a law firm and is not a substitute for a lawyer’s advice about complex estate planning. The company is backed by some venture capital firms including Revolution’s Rise of the Rest, Western TechnologyInvestments, Luma Launch, Halogen Ventures, and Techstars, as well as angel investors.Trust & Will was founded in 2017 and is headquartered in San Diego, CA. | $15M / Series B / Nov 17, 2020 | ||
| See all 12 investments → | |||
Co-Investors
About Jackson Square Ventures
Jackson Square Ventures is an an early stage venture capital firm that invests in software businesses.
Jackson Square Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bob Spinner
Managing Director
|
|||
Gregory Gretsch
Founding Partner & Managing Director
|
|||
John Otterson
Partner, Administration, and LP Relations
|
|||
Pete Solvik
Founding Partner & Managing Director
|
|||
|
Victor Echevarria
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Victor Echevarria invest in?
Victor Echevarria invests primarily in Health Care, FinTech and Hospital startups, most often at Series A and Series B stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Victor Echevarria?
Public channels for Victor Echevarria include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Victor Echevarria last invest?
The most recent investment recorded for Victor Echevarria closed in Aug 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
